Immune Responses to COVID-19 Vaccination in Lymphoma Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Chronic Lymphocytic Leukemia
- Burkitt Lymphoma
- Primary Mediastinal B Cell Lymphoma
- Classical Hodgkin Lymphoma
- Diffuse Large B Cell Lymphoma
- Follicular Lymphoma
- High Grade B Cell Lymphoma
- Lymphoplasmacytic Lymphoma
- Mantle Cell Lymphoma
- Marginal Zone Lymphoma
- Small Lymphocytic Lymphoma
- Nodular Lymphocyte Predominant Hodgkin Lymphoma
- Peripheral T Cell Lymphoma
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04858568
- Collaborators
- Not Provided
- Investigators
- Not Provided